Post-approval studies (Phase 4)Study completedNCT00624832
What this trial is testing
Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
Who this might be right for
Asthma
Novartis 60